The rising levels of cholesterol in the case of ABCA1 mutations leading to various SNPs and thus, variable protein product expression will inevitably lead to dyslipidemia, renal insufficiency, and diabetic nephropathy. The gene discussed is ABCA1; the disease is metabolic syndrome.